Supriya Lifescience Limited (SUPRIYA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.051x

Based on the latest financial reports, Supriya Lifescience Limited (SUPRIYA) has a cash flow conversion efficiency ratio of 0.051x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs555.65 Million ≈ $6.01 Million USD) by net assets (Rs10.82 Billion ≈ $116.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Supriya Lifescience Limited for the company's overall valuation and market capitalisation.

Supriya Lifescience Limited - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Supriya Lifescience Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Supriya Lifescience Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Supriya Lifescience Limited ranked by their cash flow conversion efficiency. Explore how high is Supriya Lifescience Limited's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Yieh Phui Enterprise Co Ltd TW:2023	0.038x
Shanghai Zhongyida Co Ltd A SHG:600610	0.483x
Asiainfo Security Technologies Corp. A SHG:688225	N/A
Shenzhen INVT Electric Co Ltd SHE:002334	0.060x
Forward Industries Inc NASDAQ:FORD	-0.002x
TMK KLSE:5330	N/A
Shanghai Research Institute of Building Sciences Group Co. Ltd A SHG:603153	N/A
Hunan Jingfeng Pharmaceutical SHE:000908	-3.332x

Annual Cash Flow Conversion Efficiency for Supriya Lifescience Limited (2018–2025)

The table below shows the annual cash flow conversion efficiency of Supriya Lifescience Limited from 2018 to 2025. View current stock price of Supriya Lifescience Limited for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs9.97 Billion ≈ $107.80 Million	Rs1.73 Billion ≈ $18.66 Million	0.173x	+24.58%
2024-03-31	Rs8.15 Billion ≈ $88.18 Million	Rs1.13 Billion ≈ $12.25 Million	0.139x	+46.86%
2023-03-31	Rs6.99 Billion ≈ $75.64 Million	Rs661.87 Million ≈ $7.16 Million	0.095x	+19.38%
2022-03-31	Rs6.16 Billion ≈ $66.58 Million	Rs488.01 Million ≈ $5.28 Million	0.079x	-73.33%
2021-03-31	Rs2.69 Billion ≈ $29.08 Million	Rs799.30 Million ≈ $8.64 Million	0.297x	-61.80%
2020-03-31	Rs1.49 Billion ≈ $16.13 Million	Rs1.16 Billion ≈ $12.55 Million	0.778x	+49.91%
2019-03-31	Rs937.91 Million ≈ $10.14 Million	Rs486.72 Million ≈ $5.26 Million	0.519x	+62.52%
2018-03-31	Rs546.57 Million ≈ $5.91 Million	Rs174.52 Million ≈ $1.89 Million	0.319x	--

About Supriya Lifescience Limited

NSE:SUPRIYA India Biotechnology

Market Cap

$788.84 Million

Rs72.94 Billion INR

Market Cap Rank

#10043 Global

#499 in India

Share Price

Rs906.30

Change (1 day)

+0.63%

52-Week Range

Rs553.35 - Rs1052.50

All Time High

Rs1052.50